Julio Ávila

11PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 15, 2025
Overexpression of renin-angiotensin system peptides and receptors (OVRAS) in androgen-induced PCOS mouse ovaries.

Deborah Rotoli, Frederick Naftolin, Jairo Hernández

|Aug 28, 2025
Functional Disruption of IQGAP1 by Truncated PALB2 in Two Cases of Breast Cancer: Implications for Proliferation and Invasion.

Natalia-Dolores Pérez-Rodríguez, Rita Martín-Ramírez, Rebeca González-Fernández

|Aug 27, 2025
Cilastatin Modulates DPEP1- and IQGAP1-Associated Neuro-Glio-Vascular Inflammation in Oxaliplatin-Induced Peripheral Neurotoxicity.

Rita Martín-Ramírez, María Ángeles González-Nicolás, Karen Álvarez-Tosco

|Sep 28, 2024
Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy.

Rebeca González-Fernández, Rita Martín-Ramírez, María-Del-Carmen Maeso

|Jun 24, 2022
Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment.

Manuel Morales, Pablo Martín-Vasallo, Julio Ávila

|May 14, 2022
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats.

Rebeca González-Fernández, María Ángeles González-Nicolás, Manuel Morales

Pageof 2

Frequent Collaborators

9 joint publications

Pablo Martín-Vasallo

3 joint publications

Deborah Rotoli

3 joint publications

Alberto Lázaro

3 joint publications

Rita Martín-Ramírez